SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | (FY)Jan 28, 2023 | (Q4)Jan 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 281.66%4.62B | 251.90%4.2B | -17.34%1.08B | -13.76%1.2B | -13.76%1.2B | 16.06%1.21B | 31.44%1.19B | 26.58%1.31B | 9.38%1.39B | 9.38%1.39B |
-Cash and cash equivalents | 404.22%4.58B | 368.66%4.19B | -5.40%999.9M | -19.08%921.7M | -19.08%921.7M | 13.09%909M | -1.56%894.7M | 2.13%1.06B | -10.41%1.14B | -10.41%1.14B |
-Short-term investments | -89.08%32.8M | -96.30%11.1M | -67.21%83M | 10.33%277.6M | 10.33%277.6M | 26.10%300.5M | --300M | --253.1M | --251.6M | --251.6M |
Receivables | -34.88%57.5M | -21.03%59.7M | -50.59%58.9M | -40.87%91M | -40.87%91M | -29.53%88.3M | -24.10%75.6M | 15.28%119.2M | 9.07%153.9M | 9.07%153.9M |
-Accounts receivable | -34.88%57.5M | -21.03%59.7M | -50.59%58.9M | -40.87%91M | -40.87%91M | -29.53%88.3M | -24.10%75.6M | 15.28%119.2M | 9.07%153.9M | 9.07%153.9M |
Inventory | -18.71%830.2M | -17.27%560M | -11.02%675.8M | -7.38%632.5M | -7.38%632.5M | -9.72%1.02B | -7.88%676.9M | -17.23%759.5M | -25.37%682.9M | -25.37%682.9M |
Other current assets | 106.93%119.4M | 3.45%60M | -5.62%62.1M | -46.63%51.4M | -46.63%51.4M | -79.62%57.7M | -78.98%58M | -72.62%65.8M | -64.50%96.3M | -64.50%96.3M |
Total current assets | 136.59%5.62B | 143.56%4.88B | -16.63%1.88B | -15.04%1.97B | -15.04%1.97B | -7.94%2.38B | -0.69%2.01B | -3.22%2.25B | -10.59%2.32B | -10.59%2.32B |
Non current assets | ||||||||||
Net PPE | -27.61%495.8M | -18.87%569.8M | -13.21%624.4M | -6.68%650.7M | -6.68%650.7M | 3.51%684.9M | 0.17%702.3M | -0.92%719.4M | -7.05%697.3M | -7.05%697.3M |
-Gross PPE | -23.72%1.26B | -15.99%1.42B | -14.04%1.47B | -11.87%1.5B | -11.87%1.5B | 0.90%1.66B | -0.35%1.69B | -0.70%1.71B | -4.26%1.7B | -4.26%1.7B |
-Accumulated depreciation | 20.98%-768.9M | 13.94%-846M | 14.64%-843.6M | 15.45%-851.2M | 15.45%-851.2M | 0.86%-973M | 0.72%-983M | 0.53%-988.3M | 2.23%-1.01B | 2.23%-1.01B |
Non current deferred assets | 6.63%17.7M | -0.57%17.5M | 0.00%17.5M | -5.46%17.3M | -5.46%17.3M | 16.08%16.6M | 5.39%17.6M | 4.79%17.5M | 12.27%18.3M | 12.27%18.3M |
Other non current assets | 50.73%103.4M | -17.18%65.1M | -16.77%65.5M | -9.85%66.8M | -9.85%66.8M | 6.03%68.6M | 25.76%78.6M | 48.21%78.7M | -44.70%74.1M | -44.70%74.1M |
Total non current assets | -19.89%616.9M | -18.30%652.4M | -13.27%707.4M | -6.95%734.8M | -6.95%734.8M | 3.97%770.1M | 2.33%798.5M | 2.48%815.6M | -12.30%789.7M | -12.30%789.7M |
Total assets | 98.30%6.24B | 97.46%5.54B | -15.74%2.59B | -12.99%2.71B | -12.99%2.71B | -5.29%3.15B | 0.15%2.8B | -1.77%3.07B | -11.03%3.11B | -11.03%3.11B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -39.20%494.1M | -41.67%220.5M | -49.64%282.7M | -37.67%348.8M | -37.67%348.8M | -8.52%812.7M | 73.87%378M | 45.14%561.4M | 11.54%559.6M | 11.54%559.6M |
-accounts payable | -39.20%494.1M | -41.67%220.5M | -49.64%282.7M | -39.02%324M | -39.02%324M | -8.52%812.7M | 73.87%378M | 45.14%561.4M | 12.80%531.3M | 12.80%531.3M |
-Total tax payable | ---- | ---- | ---- | -12.37%24.8M | -12.37%24.8M | ---- | ---- | ---- | -7.82%28.3M | -7.82%28.3M |
Current accrued expenses | 2.65%437M | -22.50%377.8M | -30.98%377.1M | -34.05%49M | -34.05%49M | -15.57%425.7M | -4.80%487.5M | 2.46%546.4M | -50.63%74.3M | -50.63%74.3M |
Current debt and capital lease obligation | -15.50%168.5M | -10.05%185.2M | -10.96%188.5M | -3.41%198.5M | -3.41%198.5M | 1.68%199.4M | 1.48%205.9M | 2.37%211.7M | -4.33%205.5M | -4.33%205.5M |
-Current debt | 3.81%10.9M | 0.00%11M | -0.92%10.8M | 0.00%10.8M | 0.00%10.8M | 6.06%10.5M | 23.60%11M | 67.69%10.9M | 163.41%10.8M | 163.41%10.8M |
-Current capital lease obligation | -16.57%157.6M | -10.62%174.2M | -11.50%177.7M | -3.60%187.7M | -3.60%187.7M | 1.45%188.9M | 0.46%194.9M | 0.25%200.8M | -7.59%194.7M | -7.59%194.7M |
Current deferred liabilities | ---- | ---- | ---- | -29.82%283.6M | -29.82%283.6M | ---- | ---- | ---- | 3.67%404.1M | 3.67%404.1M |
Current liabilities | -23.52%1.1B | -26.87%783.5M | -35.71%848.3M | -30.21%934.5M | -30.21%934.5M | -9.50%1.44B | 14.91%1.07B | 17.09%1.32B | -1.15%1.34B | -1.15%1.34B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -28.88%295M | -18.87%348.3M | -8.80%400.2M | -1.65%404.3M | -1.65%404.3M | 9.62%414.8M | 7.46%429.3M | 6.97%438.8M | -5.32%411.1M | -5.32%411.1M |
-Long term debt | -52.00%9.6M | -47.46%12.4M | -43.35%14.9M | -38.33%17.7M | -38.33%17.7M | -30.56%20M | -26.48%23.6M | -26.33%26.3M | -29.14%28.7M | -29.14%28.7M |
-Long term capital lease obligation | -27.71%285.4M | -17.20%335.9M | -6.59%385.3M | 1.10%386.6M | 1.10%386.6M | 12.93%394.8M | 10.42%405.7M | 10.15%412.5M | -2.87%382.4M | -2.87%382.4M |
Other non current liabilities | 30.48%41.1M | -41.06%21.1M | -22.33%31.3M | -22.74%31.6M | -22.74%31.6M | -71.47%31.5M | -71.15%35.8M | -70.73%40.3M | -62.09%40.9M | -62.09%40.9M |
Total non current liabilities | -24.69%336.1M | -20.58%369.4M | -9.94%431.5M | -3.56%435.9M | -3.56%435.9M | -8.69%446.3M | -11.17%465.1M | -12.56%479.1M | -16.62%452M | -16.62%452M |
Total liabilities | -23.80%1.44B | -24.97%1.15B | -28.84%1.28B | -23.49%1.37B | -23.49%1.37B | -9.31%1.88B | 5.53%1.54B | 7.39%1.8B | -5.57%1.79B | -5.57%1.79B |
Shareholders'equity | ||||||||||
Share capital | 100.00%200K | 100.00%200K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K |
-common stock | 100.00%200K | 100.00%200K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K | 0.00%100K |
Retained earnings | 22.76%-213.1M | 15.58%-230.3M | 9.22%-245.1M | 3.05%-212.8M | 3.05%-212.8M | -3.06%-275.9M | -57.69%-272.8M | -319.91%-270M | -334.51%-219.5M | -334.51%-219.5M |
Paid-in capital | 213.35%5.1B | 189.71%4.7B | 0.86%1.64B | 1.32%1.63B | 1.32%1.63B | 1.31%1.63B | 1.74%1.62B | 2.14%1.62B | 2.29%1.61B | 2.29%1.61B |
Gains losses not affecting retained earnings | 7.42%-82.3M | -2.22%-83M | -4.01%-83.1M | -16.27%-83.6M | -16.27%-83.6M | 5.22%-88.9M | -5.45%-81.2M | -10.06%-79.9M | -4.66%-71.9M | -4.66%-71.9M |
Total stockholders'equity | 280.46%4.8B | 245.91%4.38B | 2.81%1.31B | 1.23%1.34B | 1.23%1.34B | 1.43%1.26B | -5.68%1.27B | -12.35%1.27B | -17.49%1.32B | -17.49%1.32B |
Total equity | 280.46%4.8B | 245.91%4.38B | 2.81%1.31B | 1.23%1.34B | 1.23%1.34B | 1.43%1.26B | -5.68%1.27B | -12.35%1.27B | -17.49%1.32B | -17.49%1.32B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |